Jeffrey B. Mirviss is EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 28,454 shares of BSX, which is worth approximately $2.73 Million. The most recent transaction as insider was on Dec 03, 2020, when has been sold 649 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.5K
1.54% 3M change
49.72% 12M change
Total Value Held $2.73 Million

Jeffrey B. Mirviss Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 03 2020
BUY
Exercise of conversion of derivative security
-
649 Added 0.49%
132,132 Common Stock
Dec 01 2020
SELL
Open market or private sale
$1,561,961 $33.53 p/Share
46,584 Reduced 26.16%
131,483 Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$333,541 $7.16 p/Share
46,584 Added 20.74%
178,067 Common Stock
JBM

Jeffrey B. Mirviss

EVP&Pres, Periph Intervent
Marlborough, MA

Track Institutional and Insider Activities on BSX

Follow BOSTON SCIENTIFIC CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX